Effects of long-term erythrocytapheresis on splenic function in patients with sickle cell disease.

被引:0
|
作者
Raj, AB [1 ]
Bertolone, S [1 ]
Klapheke, P [1 ]
Burnett, D [1 ]
Suarez, C [1 ]
机构
[1] Univ Louisville, Sch Med, Louisville, KY 40292 USA
关键词
D O I
暂无
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
1387
引用
收藏
页码:238A / 238A
页数:1
相关论文
共 50 条
  • [41] LONG-TERM EFFICACY AND SAFETY OF DEFERIPRONE FOR PATIENTS WITH SICKLE CELL DISEASE OR OTHER ANEMIAS
    Elalfy, Mohsen
    Hamdy, Mona
    El-Beshlawy, Amal
    Ebeid, Fatma
    Badr, Mohammed
    Kanter, Julie
    Inusa, Baba
    Williams, Suzan
    Lee, David
    Tricta, Fernando
    Kwiatkowski, Janet L.
    [J]. PEDIATRIC BLOOD & CANCER, 2021, 68 : S14 - S14
  • [42] Erythrocytapheresis is a cost-effective strategy for the prophylactic treatment of patients with sickle cell anemia and a high probability of severe disease.
    Lerner, NB
    [J]. BLOOD, 2000, 96 (11) : 436A - 436A
  • [43] Splenic infarction as the first manifestation of S/C sickle cell disease.
    Hannat, S
    Mezalek, ZT
    Adnaoui, M
    Mohattane, A
    Aouni, M
    Maaouni, A
    Berbich, A
    [J]. SEMAINE DES HOPITAUX, 1999, 75 (35-36): : 1394 - 1396
  • [44] Effects of Erythrocytapheresis Procedures on Delayed Bone Marrow Conversion in Sickle Cell Disease
    Popham E.
    Moeller K.
    Raj A.
    [J]. Clinical Hematology International, 2022, 4 (4) : 144 - 147
  • [45] Pinch-off syndrome in patients with sickle cell disease receiving erythrocytapheresis
    Nuss, Rachelle
    Cole, Laura
    Le, Tuan
    Orsini, Edmund
    Harned, Roger
    [J]. PEDIATRIC BLOOD & CANCER, 2008, 50 (02) : 354 - 356
  • [46] TRANSFUSION-RELATED HYPERKALEMIA AFTER ERYTHROCYTAPHERESIS IN PATIENTS WITH SICKLE CELL DISEASE
    Zhao, Jun
    Pena, Elpidio
    Frazier, Angela
    Knapp, Esther
    Raj, Ashok
    [J]. PEDIATRIC BLOOD & CANCER, 2022, 69
  • [47] Filterability of sickle cells in the blood of patients with sickle cell disease.
    Shah, SP
    Graves, RM
    Li, C
    Lian, LR
    Asakura, T
    [J]. BLOOD, 1999, 94 (10) : 195A - 195A
  • [48] Long term treatment with hydroxyurea does not prevent development of renal dysfunction and osteodystrophy in patients with sickle cell disease.
    Voskaridou, E
    Terpos, E
    Margeli, A
    Hantzi, E
    Stoupa, E
    Loutradi, A
    Papassotiriou, L
    Loukopoulos, D
    [J]. BLOOD, 2004, 104 (11) : 466A - 466A
  • [49] Long-term outcome in Kawasaki Disease.
    Scuccimarri, R
    Duffy, CM
    Jutras, L
    Dancea, A
    Beland, MJ
    Love, B
    Cortopassi, M
    Morin, I
    Platt, R
    Rohlicek, C
    Duffy, KNW
    [J]. ARTHRITIS AND RHEUMATISM, 2003, 48 (09): : S648 - S648
  • [50] Long-term follow up of patients with cold agglutinin disease.
    Go, RS
    Serck, SL
    Davis, JJ
    Bottner, WA
    Cole, CE
    Farnen, JP
    Jumonville, AJ
    [J]. BLOOD, 2005, 106 (11) : 5B - 5B